Stayble Therapeutics AB (publ) (DB: 4K4)
Health Care · Pharmaceuticals · SE
€—
— today · — 1Y
Stayble Therapeutics AB (publ) (DB: 4K4) operates in the Pharmaceuticals industry within the Health Care sector.
trading between 0.00 and 0.05.
Tweenvest scores Stayble Therapeutics AB (publ) across four factors: quality 36/100. Its strongest factor is quality.
4K4 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- —
- Revenue (TTM)
- $-1.79K
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- €0.05
- 52-week low
- €0.00
- Avg volume (3M)
- —
- Shares outstanding
- —
- Employees
- 2
- Next earnings
- —
About Stayble Therapeutics AB (publ)
Stayble Therapeutics AB (publ) is dedicated to pioneering an injectable therapy aimed at treating persistent lower back pain that stems from spinal disc degeneration. The company's key development is STA363, a pharmaceutical designed as a single, minimally invasive injection administered directly into the disc to combat chronic lumbar discomfort. This Swedish firm was established in 2015 and is headquartered in Gothenburg.
- Founded
- 2015
- Listed since
- Mar 9, 2020
- Exchange
- Deutsche Boerse AG
- Currency
- EUR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.